Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Clorox logoClorox CLX

Clorox said net sales and volume for the 3 months ended September 30, 2025 decreased 19% and 18%, respectively, versus the year-ago period. The company explained the volume decrease was primarily due to lower shipments in the current period following the incremental shipments related to the ERP transition in the Q4 of fiscal 2025.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Clorox said net sales and volume for the 3 months ended September 30, 2025 decreased 19% and 18%, respectively, versus the year-ago period. The company explained the volume decrease was primarily due to lower shipments in the current period following the incremental shipments related to the ERP transition in the Q4 of fiscal 2025.

  2. Clorox said gross margin in the current period decreased from 45.8% to 41.7%, a decline of 410 basis points. The company cited lower volume and higher manufacturing and logistics costs as the primary drivers, partially offset by cost savings.

  3. The company said net cash provided by operations for the 3 months decreased to $93 from $221 in the year-ago period. As of September 30, 2025, current liabilities exceeded current assets by $539, and Clorox cited the Glad venture agreement terminal obligation due for payment in January 2026 as the primary reason.

  4. Clorox said its Glad bags and wraps venture agreement with P&G is scheduled to expire in January 2026. Upon termination, the company is required to purchase P&G's 20% interest for cash at fair value as established by predetermined valuation procedures, with the estimated fair value $476.

Key figures

Quarter ended September 30, 2025

Revenue
$1.4B
Net income
$80M
EPS
$0.65
Gross profit
$596M
Operating cash flow
$93M

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Quarterly net sales and volume decline

Clorox said net sales and volume for the 3 months ended September 30, 2025 decreased 19% and 18%, respectively, versus the year-ago period. The company explained the volume decrease was primarily due to lower shipments in the current period following the incremental shipments related to the ERP transition in the Q4 of fiscal 2025.

Source · Based on the MD&A text of the filing

Gross margin 41.7%

Clorox said gross margin in the current period decreased from 45.8% to 41.7%, a decline of 410 basis points. The company cited lower volume and higher manufacturing and logistics costs as the primary drivers, partially offset by cost savings.

Source · Based on the MD&A text of the filing

Operating cash flow and current liabilities exceed current assets

The company said net cash provided by operations for the 3 months decreased to $93 from $221 in the year-ago period. As of September 30, 2025, current liabilities exceeded current assets by $539, and Clorox cited the Glad venture agreement terminal obligation due for payment in January 2026 as the primary reason.

Source · Based on the MD&A text of the filing

Glad venture agreement termination and P&G interest purchase obligation

Clorox said its Glad bags and wraps venture agreement with P&G is scheduled to expire in January 2026. Upon termination, the company is required to purchase P&G's 20% interest for cash at fair value as established by predetermined valuation procedures, with the estimated fair value $476.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.